Maiwei Biotech (688062.SH) announced semi-annual results with a net loss of 445 million yuan

Zhitongcaijing · 08/30 13:33

According to Zhitong Finance App News, Maiwei Biotech (688062.SH) disclosed its 2024 semi-annual report. During the reporting period, the company achieved revenue of 116 million yuan, an increase of 28.42% over the previous year; net profit loss to mother of 445 million yuan, a year-on-year increase; loss after deducting non-net profit of 461 million yuan, a year-on-year increase; and basic earnings per share - 1.11 yuan.